Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Lisa M. Jack"'
Autor:
R Scott Runyon, Leslie M Cachola, Nitya Rajeshuni, Tessa Hunter, Marco Garcia, Regina Ahn, Fred Lurmann, Ruth Krasnow, Lisa M Jack, Rachel L Miller, Gary E Swan, Arunima Kohli, Amanda C Jacobson, Kari C Nadeau
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48796 (2012)
T cells mediate the inflammatory responses observed in asthma among genetically susceptible individuals and have been suspected to be prone to epigenetic regulation. However, these relationships are not well established from past clinical studies tha
Externí odkaz:
https://doaj.org/article/64d03663f1ed452989513bc84f3c6dbd
Autor:
David P.L. Sachs, Janet Brigham, Bonnie L. Sachs, Susan J.S. Waldron, Gary E. Swan, Betsy L. Titus, Lisa M. Jack, John E. Hodgkin
Publikováno v:
Mayo Clinic Proceedings. 88:970-976
St. Helena Hospital launched the first US residential stop-smoking program, The St. Helena Center for a Smoke-Free Life, in 1969. This observational report describes the center's treatment outcome rate for using a patient-centered approach to the use
Autor:
Jennifer B. McClure, Harold S. Javitz, Gary E. Swan, Julie Richards, Tim McAfee, Sheryl L. Catz, Mona Deprey, Lisa M. Jack, Susan M. Zbikowski
Publikováno v:
Nicotine & Tobacco Research. 13:361-368
Patient adherence to smoking cessation medications can impact their effectiveness. It is important to understand the extent to which prescribed medications are actually taken by smokers, how this influences smoking cessation outcomes, and what factor
Autor:
Dennis G. Ballinger, Jennifer B. McClure, Renee Stokowski, Ruth Krasnow, David A. Hinds, Andrew W. Bergen, Jennifer Wessel, Jill Hardin, Harold S. Javitz, Michael I. Kennemer, Sarah M McDonald, Steven J Pitts, Gary E. Swan, Martha Michel, William Dirks, Lisa M. Jack
Publikováno v:
Neuropsychopharmacology. 35:2392-2402
Common single-nucleotide polymorphisms (SNPs) at nicotinic acetylcholine receptor (nAChR) subunit genes have previously been associated with measures of nicotine dependence. We investigated the contribution of common SNPs and rare single-nucleotide v
Autor:
Susan M. Zbikowski, Sheryl L. Catz, Julie Richards, T. Mona Deprey, Lisa M. Jack, Jennifer B. McClure, Timothy A. McAfee, Abigail C. Halperin, Gary E. Swan
Publikováno v:
Journal of Substance Abuse Treatment. 36:428-434
This paper examines reported symptoms, nonsmoking rates, and medication use among 1018 smokers using varenicline in a randomized trial comparing three forms of behavioral support for smoking cessation (phone, web, or phone + web). One month after beg
Publikováno v:
CNS Drugs. 22:239-256
Aim: To examine heterogeneity in outcome at 12 months following 8 weeks of treatment for smoking cessation with bupropion sustained-release (SR) 150 or 300 mg/day combined with behavioural counselling. Design, setting, participants: Smokers were recr
Autor:
Timothy A. McAfee, Donna L. Decker, Richard Patterson, Lisa M. Jack, Susan J. Curry, Harold S. Javitz, Gary E. Swan, Susan M. Zbikowski
Publikováno v:
Value in Health. 7:535-543
The net benefit (i.e., benefits minus costs) of sustained-release (SR) bupropion for smoking cessation from an employer's perspective has previously been evaluated in clinical trials including frequent, in-person behavioral counseling and manufacture
Publikováno v:
Addiction. 99:237-250
Aims To examine heterogeneity in outcome following treatment for smoking cessation with combined bupropion SR and behavioral counseling in women and men. Design, setting, participants This study included 875 women and 649 men recruited from a large h
Autor:
Michael Chorost, Tim McAfee, Harold S. Javitz, Gary E. Swan, Sara Dacey, Lisa M. Jack, Sue Curry
Publikováno v:
Nicotine & Tobacco Research. 5:911-921
To date, only one study has been published on individual characteristics associated with outcome following standard treatment with bupropion SR for smoking cessation. To investigate treatment outcome beyond the 6-week end-of-treatment point, the pres
Autor:
Ella Thompson, Katherine Bergman, Lisa M. Jack, Timothy A. McAfee, Sara Dacey, Susan J. Curry, Gary E. Swan
Publikováno v:
Preventive Medicine. 36:585-593
Background Little is known about the effectiveness of bupropion SR for smoking cessation outside the context of clinical efficacy trials, where in-person screening and treatment occur at a higher level than provided in a typical health care system. T